AM8191 is an orally active bactericidal agent that selectively inhibits DNA synthesis and targets Staphylococcus aureus gyrase (IC50 = 1.02 μM) and topoisomerase IV (IC50 = 10.4 μM); it exhibits potent inhibitory activity against methicillin-sensitive Staphylococcus aureus (MSSA; IC50 = 0.02 μg/mL) and methicillin-resistant Staphylococcus aureus (MRSA; IC50 = 0.06 μg/mL).